Bausch + Lomb (BLCO) vs Innovative Eyewear (LUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Bausch + Lomb is the larger company by market cap ($6.93 billion vs $6.1 million), about 1132.0 times the size, while Innovative Eyewear is growing revenue faster (+62.6% vs +6.5%). Bausch + Lomb converts more of its revenue into profit, with a net margin of -7.1% versus -285.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLCO | LUCY |
|---|---|---|
| Share price | $19.38 | $0.7025 |
| Market cap | $6.93B | $6.12M |
| 1-day change | -6.33% | -0.07% |
| YTD return | +13.47% | — |
| 1-year return | +28.60% | — |
| Forward P/E | 16.36 | — |
| EPS (TTM) | $-0.32 | $-1.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.10B | $2.66M |
| Revenue growth (YoY) | +6.47% | +62.65% |
| Net income (latest FY) | $-360.00M | $-7.59M |
| Gross margin | — | 21.32% |
| Operating margin | 2.22% | — |
| Net margin | -7.06% | -285.20% |
| 52-week high | $21.40 | $2.00 |
| 52-week low | $14.65 | $0.65 |
| Distance from 52-week high | -9.44% | -64.88% |
| Analyst consensus | buy | — |
| Avg. price target upside | +13.16% | — |
| Average volume | 660.67K | 3.52M |
| Shares outstanding | 357.50M | 8.71M |
| Employees | 13,000 | 13 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bausch + Lomb is about 1132.0 times larger than Innovative Eyewear by market value ($6.93B vs $6.12M).
- Bausch + Lomb is more profitable, keeping -7.1 cents of every revenue dollar as net income versus -285.2 cents for Innovative Eyewear.
- Innovative Eyewear grew revenue faster in its latest fiscal year (+62.65% vs +6.47%).
About Bausch + Lomb
BLCO stock →Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical.
Health Care · Ophthalmic Goods · 13,000 employees
About Innovative Eyewear
LUCY stock →Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Health Care · Ophthalmic Goods · 13 employees
BLCO vs LUCY FAQ
Which is bigger, Bausch + Lomb or Innovative Eyewear?
Bausch + Lomb (BLCO) is larger, with a market capitalization of $6.93B compared with $6.12M for Innovative Eyewear (LUCY).
Are Bausch + Lomb and Innovative Eyewear in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.